In addition, the concentration of CPN1 fluctuated in patients with triple-negative breast cancer (TNBC) and in patients treated extensively with chemotherapy compared to CA153 (Additional file 1: Figs. S3, S4). Here, CPN1 is linked to triple-negative breast carcinoma.